Can liquid biopsies for MASH help increase the penetration of metabolic surgery? A narrative review
This narrative review highlights current evidence on non-invasive tests to predict the presence or absence as well as the severity of metabolic dysfunction-associated steatohepatitis (MASH) and liver fibrosis. Metabolic dysfunction-associated steatotic liver disease (MASLD) is a common condition characterized by fat accumulation in the liver that affects 32 % of the world population. The most severe form of MASLD is MASH in which hepatocyte ballooning and inflammation are present together with steatosis; MASH is often associated with liver fibrosis.
Source: Metabolism - Clinical and Experimental - Category: Biomedical Science Authors: Lidia Castagneto-Gissey, Stefan R. Bornstein, Geltrude Mingrone Source Type: research